phase readout
saveNCT07660094: Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
RECRUITINGupdated 48m ago
community read0 votes
Sponsor: Candel Therapeutics, Inc.. Phase: PHASE3. Conditions: Non-squamous, Non-Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that